Exo Imaging

Exo Imaging has 2 AI-enabled medical devices on the FDA list. The first decision was on August 5, 2024 and the most recent on February 24, 2026 (AI Platform 2.2 (AIP002)). Its most common review panel is Radiology (2 devices).